Page last updated: 2024-10-29

ketanserin and Familial Primary Pulmonary Hypertension

ketanserin has been researched along with Familial Primary Pulmonary Hypertension in 2 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Familial Primary Pulmonary Hypertension: Familial or idiopathic hypertension in the PULMONARY CIRCULATION which is not secondary to other disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delaney, C1
Gien, J1
Roe, G1
Isenberg, N1
Kailey, J1
Abman, SH1
Liu, Y1
Tian, H1
Yan, X1
Fan, F1
Wang, W1
Han, J1

Other Studies

2 other studies available for ketanserin and Familial Primary Pulmonary Hypertension

ArticleYear
Serotonin contributes to high pulmonary vascular tone in a sheep model of persistent pulmonary hypertension of the newborn.
    American journal of physiology. Lung cellular and molecular physiology, 2013, Jun-15, Volume: 304, Issue:12

    Topics: Adult; Animals; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Familial Primary Pulmona

2013
Serotonin inhibits apoptosis of pulmonary artery smooth muscle cells through 5-HT2A receptors involved in the pulmonary artery remodeling of pulmonary artery hypertension.
    Experimental lung research, 2013, Volume: 39, Issue:2

    Topics: Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Familial Primary Pu

2013